A previous study identified VHL mutations as the most common gene mutation (72%), followed by PBRM1 (45%), SETD2 (34%), and BAP1 mutations (17%) in 29 Caucasian patients with advanced ccRCC (21). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.